Noninvasive Diagnosis of the Mitochondrial Function of Doxorubicin-Induced Cardiomyopathy Using In Vivo Dynamic Nuclear Polarization-Magnetic Resonance Imaging
Doxorubicin (DOX) induces dose-dependent cardiotoxicity via oxidative stress and abnormal mitochondrial function in the myocardium. Therefore, a noninvasive in vivo imaging procedure for monitoring the redox status of the heart may aid in monitoring diseases and developing treatments. However, an appropriate technique has yet to be developed. In this study, we demonstrate a technique for detecting and visualizing the redox status of the heart using in vivo dynamic nuclear polarization-magnetic resonance imaging (DNP-MRI) with 3-carbamoyl-PROXYL (CmP) as a molecular imaging probe. Male C57BL/6N mice were administered DOX (20 mg/kg) or saline. DNP-MRI clearly showed a slower DNP signal reduction in the DOX group than in the control group. Importantly, the difference in the DNP signal reduction rate between the two groups occurred earlier than that detected by physiological examination or clinical symptoms. In an in vitro experiment, KCN (an inhibitor of complex IV in the mitochondrial electron transport chain) and DOX inhibited the electron paramagnetic resonance change in H9c2 cardiomyocytes, suggesting that the redox metabolism of CmP in the myocardium is mitochondrion-dependent. Therefore, this molecular imaging technique has the potential to monitor the dynamics of redox metabolic changes in DOX-induced cardiomyopathy and facilitate an early diagnosis of this condition.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Antioxidants (Basel, Switzerland) - 11(2022), 8 vom: 26. Juli |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mizuta, Yukie [VerfasserIn] |
---|
Links: |
---|
Themen: |
Dynamic nuclear polarization–magnetic resonance imaging |
---|
Anmerkungen: |
Date Revised 31.07.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/antiox11081454 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM344124452 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM344124452 | ||
003 | DE-627 | ||
005 | 20231226022037.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/antiox11081454 |2 doi | |
028 | 5 | 2 | |a pubmed24n1147.xml |
035 | |a (DE-627)NLM344124452 | ||
035 | |a (NLM)35892655 | ||
035 | |a (PII)1454 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mizuta, Yukie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Noninvasive Diagnosis of the Mitochondrial Function of Doxorubicin-Induced Cardiomyopathy Using In Vivo Dynamic Nuclear Polarization-Magnetic Resonance Imaging |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 31.07.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Doxorubicin (DOX) induces dose-dependent cardiotoxicity via oxidative stress and abnormal mitochondrial function in the myocardium. Therefore, a noninvasive in vivo imaging procedure for monitoring the redox status of the heart may aid in monitoring diseases and developing treatments. However, an appropriate technique has yet to be developed. In this study, we demonstrate a technique for detecting and visualizing the redox status of the heart using in vivo dynamic nuclear polarization-magnetic resonance imaging (DNP-MRI) with 3-carbamoyl-PROXYL (CmP) as a molecular imaging probe. Male C57BL/6N mice were administered DOX (20 mg/kg) or saline. DNP-MRI clearly showed a slower DNP signal reduction in the DOX group than in the control group. Importantly, the difference in the DNP signal reduction rate between the two groups occurred earlier than that detected by physiological examination or clinical symptoms. In an in vitro experiment, KCN (an inhibitor of complex IV in the mitochondrial electron transport chain) and DOX inhibited the electron paramagnetic resonance change in H9c2 cardiomyocytes, suggesting that the redox metabolism of CmP in the myocardium is mitochondrion-dependent. Therefore, this molecular imaging technique has the potential to monitor the dynamics of redox metabolic changes in DOX-induced cardiomyopathy and facilitate an early diagnosis of this condition | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a dynamic nuclear polarization–magnetic resonance imaging | |
650 | 4 | |a heart | |
650 | 4 | |a mitochondria | |
650 | 4 | |a nitroxyl radical | |
650 | 4 | |a oxidation reduction | |
700 | 1 | |a Akahoshi, Tomohiko |e verfasserin |4 aut | |
700 | 1 | |a Eto, Hinako |e verfasserin |4 aut | |
700 | 1 | |a Hyodo, Fuminori |e verfasserin |4 aut | |
700 | 1 | |a Murata, Masaharu |e verfasserin |4 aut | |
700 | 1 | |a Tokuda, Kentaro |e verfasserin |4 aut | |
700 | 1 | |a Eto, Masatoshi |e verfasserin |4 aut | |
700 | 1 | |a Yamaura, Ken |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Antioxidants (Basel, Switzerland) |d 2012 |g 11(2022), 8 vom: 26. Juli |w (DE-627)NLM256601127 |x 2076-3921 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2022 |g number:8 |g day:26 |g month:07 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/antiox11081454 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2022 |e 8 |b 26 |c 07 |